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Objective: There is uncertainty as to whether asthma has an effect on final height.
We investigated using subjective and objective assessments whether untreated
asthma is associated with final height, leg length and sitting height to leg length
ratio in an area of Chile in which almost no one received asthma treatment.
Methods: We collected data on 1232 males and females aged 22–28 years in a semi-
rural area of Chile. Information on asthma was collected using the European
Community Respiratory Health Survey (ECRHS) questionnaire. We assessed sensitisa-
tion to eight allergens and bronchial hyper-responsiveness (BHR) to methacholine as
a dichotomous variable and as a log slope. Information on possible confounders in
terms of smoking, birth weight, number of siblings and socio-economic factors such
as household possessions, car ownership and education was available.
Results: Regardless of the asthma assessment used, there was no association
between asthma symptoms, diagnosis of asthma, atopy, BHR as log slope, binary or
categorical and height, leg length or the ratio of sitting height to leg length. The
latter was used as a potentially more appropriate measure to assess a detriment of
growth.
Conclusion: Asthma as assessed in community studies is unrelated to final height or
body proportions.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserv
7848 6618;
ac.uk (R.J. Rona).Introduction
Early studies on the association between asthma
and height demonstrated that asthma rarely, if at
all, was the cause of severe height deterioration,1,2
but asthma was associated with some loss of heighted.
ARTICLE IN PRESS
R.J. Rona et al.912in children,3 especially during adolescence.4,5 This
decrease of height was unrelated to steroidal
treatment.6 However, Balfour-Lynn7 concluded that
asthma had no direct influence on growth in height
but was associated with delay in the onset of
puberty.
The studies in the 1970s were carried out before
standardised questionnaires for assessing asthma
became available.8,9 As there is no gold standard
for asthma, standardised tools to assess asthma are
of great value in making comparisons between
studies. In addition, since 1970 there has been a
movement away from associating asthma with
stigma and diagnostic practices have changed. As
a result there is not a clear equivalence between
subjects diagnosed as having asthma and those
diagnosed in the 1970s. In more recent studies of
height, there have been serious methodological
problems in disentangling the effects of asthma
from the effects of steroidal treatment. The
current understanding is that asthma results in a
delayed puberty and that would explain most of the
short-lived height deficit.10 However, the conclu-
sion was based on the early-published work.4,5,7,11
Most recent studies of height have tried to assess
the possible effect of inhaled preventives of
asthma such as budesonide and nedocromil.12,13
Inhaled steroids may have no lasting effect on
height and their effect may be restricted to the
early period of treatment.12 The current under-
standing is that if asthma and inhaled steroids have
an effect on height, their effect is small.
We carried out a community study of young adults
living in a semi-rural area of Chile. The population is
highly interesting because asthma symptoms are
prevalent in Chile,14 but outside the larger cities
very few subjects have received appropriate man-
agement for their condition. It is a suitable popula-
tion for assessing whether asthma on its own affects
the final height of young adults, as a large
percentage would have started their symptoms in
childhood. We also assessed the sitting height/leg
length ratio as it has been indicated that in
nutritional stress leg length is more susceptible to
growth interruption than the upper segment.15–17 We
are unaware of any asthma studies that have
assessed this ratio as an outcome variable of asthma.Methods
Subjects
This was a non-concurrent longitudinal study
centered on Limache, a semi-rural area of approxi-mately 50,000 inhabitants about 120 km north-west
of Santiago in Chile. Between 2001 and 2003, we
collected information on 1232 subjects randomly
selected using the birth register which included
3096 men and women born in the hospital of
Limache between 1974 and 1978. We chose
Limache for our study because of the high quality
of the hospital birth registry and medical records in
the first year of life, as these data were essential
for other aims of the study. The low emigration rate
in this population ensured that a large proportion of
those born in Limache would remain in the area and
could be found.Respiratory symptoms, atopy and pulmonary
function assessments
Participants completed the Spanish version of the
European Community Respiratory Health Survey
(ECRHS) questionnaire adapted to Chile.9 Skin test
sensitisations to cat fur, dog hair, cockroach,
Dermatophagoides Pteronyssinus, Alternaria Alter-
nata, and blends of grass pollens, trees, and weeds
and shrubs common in Chile were assessed (samples
obtained from Allergy Therapeutics). A wheal size
of 3mm or over was considered positive. Following
advice, this was unadjusted for histamine con-
trol.18 We assessed bronchial hyper-responsiveness
(BHR) to methacholine using the tidal breathing
methodology.19 Increasing concentrations of 0.5,
1.00, 4.00, 8.00 and 16mg/ml were used with a
Hudson nebuliser at a flow rate of 0.13 l/min over a
period of 2min. Forced expiratory volume at 1 s
(FEV1) was measured using a Vitalograph 2120 and
software Spirotrac IV following the American
Thoracic Society norms.20 An FEV1 decrease of
20% in comparison to baseline FEV1 at any con-
centration up to 16mg/ml (PC20) was considered to
have positive BHR. We also subdivided BHR re-
sponse into three groups: positive response at a
methacholine concentration up to 8mg/l, positive
response to a concentration between 8.1 and
16mg/l and negative BHR status. Participants were
advised not to smoke, or take asthma relievers and
preventives before the test for at least 1 and 6 h,
respectively. Those with an expected FEV1 below
70% of the predicted value, and those with a heart
condition, epilepsy, current pregnancy or breast-
feeding were excluded (2% of the sample). The
tests and measurements were carried out in a
health setting with ready access to medical facil-
ities. Three university nurses trained for the study
administered the questionnaire and carried out the
tests. The Ethics Committee of the Faculty of
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study.
Height was measured as recommended by Ha-
bicht and sitting height was measured in all
respects as height, but the thighs were in a
horizontal plane, the feet firmly on the ground
and the two measurements were taken to the
nearest 1mm below.21 We also collected informa-
tion on gender, age, current smoking, participant’s
education, number of household possessions, car
ownership and number of brothers and sisters. The
household possessions were a gas-fuelled water-
heating device known as a calefont, refrigerator,
washing machine and microwave oven. Education,
household belongings and car ownership were used
as indicators of socio-economic level. We also
obtained birth weight from the hospital birth
registry. Midwives measured weight following
norms published by the Ministry of Health. The
norms describe the equipment and advise staff to
adjust for the weight of any garment put on the
scales to protect the baby. The measurement
techniques are illustrated, and summarily ex-
plained.Analysis
The current analysis is cross-sectional, except that
adjustment for birth weight used information
collected at birth. The main aim was assessed by
carrying out a series of multiple regression analyses
in which the outcome variables were height, leg
length or sitting height/leg length analysed sepa-
rately and the main explanatory variables were
asthma symptoms, BHR or atopy. The asthma
variables assessed were wheeze in the last 12
months, waking with breathlessness in the last 12
months, the two asthma symptoms together,
diagnosed asthma, diagnosed asthma in childhood,
atopic status, wheeze and atopic status, BHR
status, BHR response divided into three categories
and BHR log slope. In all our analyses we adjusted
for number of cigarettes smoked per day, gender,
birth weight, number of household belongings, car
ownership, participant’s level of education and
number of siblings in the family.
In the ECRHS, a dose–response slope was adopted
as a measure of BHR.21 This method has the
advantage of minimising censored information in
comparison with the BHR status as defined by a 20%
fall in FEV1. We estimated an equivalent BHR slope
by regressing percentage fall in FEV1 on log10
concentration, referred to as BHR log slope. The
BHR log slope satisfied the statistical requirements
of normality and homocedasticity. We excluded 55participants from the analysis related to BHR log
slope because their values represented extreme
deviations to the left or right of the distribution.
The ratio of sitting height to leg length was used
as a measure of proportional contribution to total
height, as it might be more relevant in terms of
undernutrition. Leg length was calculated as the
difference between height and sitting height.Results
Altogether, 10.5% of the selected sample did not
participate in the study because they refused to
participate, were serving a custodial sentence or
had a learning disability and were randomly
replaced using the original sampling frame. Two
per cent were excluded from the BHR test. Eight
participants failed to perform the lung function
test satisfactorily. Data for all variables in the
analyses were almost 100% complete for each
participant, with the exception related to BHR log
slope explained in the analysis section.
Woken by breathlessness (P ¼ 0:002), positive
BHR (Po0:001), and diagnosed asthma (P ¼ 0:018)
among the asthma variables were more common in
women than men (Table 1). Wheeze and waking
with breathlessness in the last 12 months, and
atopy were highly prevalent. Only two subjects
have ever received steroidal treatment for their
asthma in our study, and it was sporadic. The
proportion of participants reporting asthma was
very low (4.5%). Of those who had been diagnosed
with asthma, 79% of males and 71% of females were
diagnosed as such in childhood. These percentages
exclude three currently asthmatic women who did
not give information on asthma in childhood, two
males who gave information on childhood asthma
but not on current asthma and two males who were
in remission. Families tended to have a large
number of siblings and current smoking was highly
prevalent in comparison to the US and northern
Europe (Table 1). Adult height was well below
norms for developed countries.
Height was highly correlated with leg length and
sitting height (Table 2). Leg length and the sitting
height to leg length ratio were highly correlated
negatively. The other correlations were of inter-
mediate magnitude.
Height was unrelated to asthma symptoms,
diagnosed asthma, diagnosed asthma in childhood,
wheeze and atopic status, HBR status and BHR log
slope (Table 3). It was also unrelated to BHR status
divided into three categories (not shown). Unsur-
prisingly, given the high correlation between height
and leg length, there was also no association
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Table 2 Pearson’s correlations between the anthropometric measurements in the analysis.
Height Leg length Sitting height Sitting height to leg length ratio
Height 1.00
Leg length 0.91 1.00
Sitting height 0.83 0.52 1.00
Sitting height to leg length ratio 0.41 0.75 0.16 1.00
Table 1 Prevalence of asthma variables, mean height, prevalence of smoking and family size by gender.
Variable Males (N ¼ 556) Females (N ¼ 676)
Wheeze in last 12m (%) 147 (26.4) 189 (28.0)
Woken by breathlessness (%) 58 (10.4) 111 (16.4)
Positive BHR (%) 45 (8.1) 111 (16.4)
BHR (log slope and SD) 0.318 (1.945) 0.488 (2.209)
Atopic to at least one allergen (%) 159 (28.6) 186 (27.5)
Diagnosed asthma (%) 14 (2.5) 35 (5.2)
Diagnosed asthma in childhood (%) 15 (2.7) 25 (3.7)
Adult height (cm and SD) 168.2 (6.0) 156.3 (5.5)
Leg length (cm and SD) 79.0 (4.1) 71.9 (3.7)
Current smokers (%) 379 (68.2) 344 (50.9)
Number of siblings
0 or 1 (%) 77 (13.9) 90 (13.4)
2 or 3 (%) 242 (43.6) 281 (41.8)
X4 (%) 236 (42.5) 301 (44.8)
Table 3 Association between asthma in terms of subjective and objective assessments and height, leg length
and sitting height to leg length ratio adjusted for gender, number of siblings, number of household belongings,
birth weight, smoking, car ownership, and last year of fulltime education.
Height Leg length Sitting height to leg
length ratio
No ¼ 1190 No ¼ 899 No ¼ 899
Coefficientz(95% CI) Coefficientz(95%CI) Coefficientz(95%CI)
Wheezey 0.58 (0.12, 1.28) 0.39 (0.18, 0.96) 0.007 (0.017, 0.003)
Waking with
breathlessnessy
0.54 (0.35, 1.44) 0.41 (0.30, 1.13) 0.002 (0.014, 0.010)
Wheeze and waking with
breathlessnessy
1.07 (0.15, 2.28) 0.89 (0.10, 1.88) 0. 011 (0.028, 0.006)
Diagnosed asthma 0.44 (1.13, 2.01) 0.04 (1.18, 1.26) 0.003 (0.018, 0.025)
Diagnosed asthma in
childhood
0.26 (1.99, 1.47) 0.10 (1.24, 1.44) 0.003 (0.021, 0.026)
Atopic 0.35 (1.04, 0.33) 0.55 (1.10, 0.01) 0.007 (0.003, 0.016)
Wheezey and atopic 0.20 (1.23, 0.84) 0.57 (1.41, 0.27) 0.003 (0.012, 0.017)
Positive BHR 0.26 (1.19, 0.68) 0.43 (1.20, 0.34) 0.004 (0.009, 0.017)
BHR (log slope) 0.03 (0.13, 0.18) 0.06 (0.17, 0.06) 0.002 (0.0005, 0.004)
Minimum number for some variables had two less subjects, except for BHR (log slope) in which 1122 subjects were included
for height and 848 for the other two outcomes.
yIn the last 12 months.
zAll coefficients were statistically insignificant.
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ratio of sitting height to leg length was also
unrelated to the explanatory variables.Discussion
In a population in which inhalers have been seldom
used, we were able to confirm that asthma in the
community, regardless of type of assessment, was
unrelated to final height, leg length and the sitting
height to leg length ratio.
The strengths of this study are that it was
community based, asthma was assessed using
standardised tools and the assessments were based
on subjective and objective measurements, anthro-
pometric measurements were taken using standar-
dised protocols,22 final height should have been
achieved in the total sample at the age of 22–28
years and a large suitable control group was
available similar in all characteristics, except their
asthma status. As participants were young adults,
physical shrinkage, if any, was minimal. As this was
a community study, we suspect that most of the
asthmatic subjects had either mild or moderate
asthma. It is possible that in a study including only
patients with severe asthma an effect on height
could have been found. However, such a study
would have selected patients known to physicians,
who might be more likely to receive steroidal
treatment thus making it difficult to distinguish the
asthma from the steroids effect on height or other
anthropometric measurement.
The cross-sectional design of our study should not
have affected our results because we were able to
measure our outcomes accurately, recall bias would
have been unlikely because the fieldworkers and
the participants supplying the information on
asthma were unaware of the hypothesis being
tested and reverse causality, say height causing
asthma, would be less likely after adjusting for
gender, birth weight, smoking and socio-economic
factors. The main weakness of this study was that
asthma might have started in adulthood in a
proportion of the subjects and this would have
increased the risk of misclassification, as asthma
onset in adulthood could not have influenced our
anthropometric measurement outcomes. As most
of the questions on asthma symptoms did not
explore early onset, and atopy and BHR were
assessed in adulthood, we were uncertain about
the percentage of participants whose asthma
symptoms, atopy and positive BHR started in
childhood. Approximately three quarters of those
with diagnosed asthma reported having their
asthma since childhood. Unfortunately in semi-rural areas in developing countries, only a small
proportion of individuals with asthma symptoms
receive a recorded diagnosis of asthma from a
doctor. This is the reason why the number of
subjects with asthma symptoms in our study was
disproportionately high in comparison to subjects
with physician-diagnosed asthma. We believe that
approximately between 65% and 80% of those with
asthma symptoms started their symptoms in child-
hood. These percentage would broadly correspond
to a longitudinal study carried out in a different
setting in Australia.23 Wheeze on its own was
probably a less useful variable in our study because
many of those with current wheeze might have
experienced it only recently in adulthood thus
having little chance of influencing height. The
suggestion that a large proportion of wheeze
started in adulthood in our study is plausible
because the prevalence of smoking in young adults
in Chile is approximately 50%.24 Thus a large
percentage of individuals with wheeze may be
developing chronic bronchitis and some may in the
future develop chronic obstructive pulmonary dis-
ease rather than asthma. It is difficult to distinguish
between the three conditions in young adults.
Those with atopy and wheeze are more likely to
have started their condition in childhood, but it is
possible that some had atopy in childhood and
wheeze later in adulthood.23 We speculate that the
percentage who started their symptoms in child-
hood was higher in those who reported waking with
breathlessness compared to those who said they
had wheeze.
Undernutrition in infancy was common in Chile in
the 1970s. Although at the time infant mortality
was decreasing, the levels were 60–40 per 1000 in
the period 1974–1978, when our subjects were
born.25 The participants are a random sample of
those who survived childhood and their average
height in males is 6 cm less than the Spanish
population in the 1990s, a population of partially
similar genetic endowment to the Chilean popula-
tion.26 We would have expected that if asthma has
an effect on height it would be more noticeable in a
population already nutritionally vulnerable. How-
ever, regardless of the outcome measure of asthma
chosen or the measure of length included, there
was not a single significant association. Gunnell et
al.15 have contrasted results related to height and
leg length trying to disentangle the association
between anthropometric measurements and speci-
fic cause mortality based on their contention that
leg length is more related to nutrition than height.
However, we have demonstrated in this study that
the correlation between height and leg length is so
high that a distinction between these two measures
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ratio of sitting height to leg length might have
provided a different perspective from height
because it has been proposed that when growth in
children is being threatened, the head and the
body are protected in detriment to the limbs.
However, in our study the asthma variables were
unrelated to the sitting height to leg length ratio.
Our study is compatible with the view that
asthma may have a small detrimental effect on
height in childhood,27 a greater effect during
adolescence through delayed puberty,4,11 but its
effect is transient and will disappear in adulthood.
Such a conclusion would have been suspected from
the results presented by Agertorf and Pedersen,12
in a mostly inhaled steroid-treated population. The
fact that our population was conversely mostly
untreated enhanced the view that asthma itself has
a small effect on final height. Hauspie et al.4 in
their mixed-longitudinal analysis were able to
demonstrate this pattern of growth in asthmatic
children. However, they were unable to demon-
strate that the final height of asthmatic subjects
would be similar to non-asthmatics as reference
values based on children born before their study
were used for controls. Thus the lack of a
significant difference may not have accounted for
the secular trend of height in Belgium,28 but also
their slightly lower height may have been caused by
steroidal treatment in their sample. We did not
have these two limitations because our non-asth-
matic subjects were born at the same time and the
asthmatics seldom received steroidal treatment.
Large studies based on military drafts in Sweden
and Israel did not reach similar conclusions.29,30
The Israeli study did not find any difference in
height, if anything non-asthmatics were slightly
shorter while the Swedish study found that asth-
matics were slightly shorter. These studies had the
same limitation as our study, i.e. that the onset of
asthma may have been recent in a subset of
asthmatic subjects. In addition, there is uncer-
tainty about the effect of inhaled steroids on the
height of asthmatics.
In conclusion, our study demonstrates that final
height is unlikely to be affected by mild or
moderate asthma even in a population which may
have suffered moderate levels of undernutrition in
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